12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          To compare on the bench the physical and mechanical properties of Magmaris, a magnesium bioresorbable scaffold (BRS), with Absorb and DESolve polymeric BRS and a permanent metallic stent.

          Background

          Understanding the mechanical and physical properties of BRS is crucial for appropriate implantation and postdilatation.

          Methods

          Testing was performed in fluid at 37°C and in silicone bifurcation phantoms with a 30° angle between main branch (MB) and side branch.

          Results

          The 3.0‐mm Magmaris BRS did not fracture after MB postdilatation up to 4.4 mm in contrast to the Absorb where the safe postdilatation diameter was 3.7 mm. For dilatation through stent cells, there were no Magmaris fractures with 3.0‐mm noncompliant (NC) balloons inflated to nominal pressure. Mini‐kissing balloon postdilatation with two 3.0‐mm NC balloons up to 17 atm was without fracture except for an outlier. Longitudinal and radial strengths were similar for Magmaris and Absorb BRS. The crossing profile for the Magmaris was larger than other devices. Recoil 120 min after deployment was the greatest for Magmaris but 120 min after 3.5 mm postdilatation all devices had similar diameters.

          Conclusions

          The Magmaris BRS was more resistant to strut fracture than Absorb. It had a larger crossing profile than other devices and similar radial and longitudinal strengths to Absorb. While recoil after deployment was greater with Magmaris, 120 min after 3.5 mm postdilatation all devices had similar diameters.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.

          No medium-term data are available on the random comparison between everolimus-eluting bioresorbable vascular scaffolds and everolimus-eluting metallic stents. The study aims to demonstrate two mechanistic properties of the bioresorbable scaffold: increase in luminal dimensions as a result of recovered vasomotion of the scaffolded vessel.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

            In patients with coronary artery disease who receive metallic drug-eluting coronary stents, adverse events such as late target-lesion failure may be related in part to the persistent presence of the metallic stent frame in the coronary-vessel wall. Bioresorbable vascular scaffolds have been developed to attempt to improve long-term outcomes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Bioresorbable Scaffolds versus Metallic Stents in Routine PCI

              Bioresorbable vascular scaffolds were developed to overcome the shortcomings of drug-eluting stents in percutaneous coronary intervention (PCI). We performed an investigator-initiated, randomized trial to compare an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in the context of routine clinical practice.
                Bookmark

                Author and article information

                Contributors
                trio@clin.au.dk
                Journal
                Catheter Cardiovasc Interv
                Catheter Cardiovasc Interv
                10.1002/(ISSN)1522-726X
                CCD
                Catheterization and Cardiovascular Interventions
                John Wiley & Sons, Inc. (Hoboken, USA )
                1522-1946
                1522-726X
                11 November 2019
                December 2020
                : 96
                : 7 ( doiID: 10.1002/ccd.v96.7 )
                : E674-E682
                Affiliations
                [ 1 ] Aarhus University Hospital Aarhus Denmark
                [ 2 ] Intra Auckland New Zealand
                [ 3 ] University of Auckland Auckland New Zealand
                Author notes
                [*] [* ] Correspondence

                Trine Ø. Barkholt, Department of Cardiology, Aarhus University Hospital, Palle Juul‐Jensens Boulevard 99, 8200 Aarhus, Denmark.

                Email: trio@ 123456clin.au.dk

                Author information
                https://orcid.org/0000-0002-7415-6724
                Article
                CCD28545
                10.1002/ccd.28545
                7754471
                31710149
                96afebd1-5fe1-4b76-b13f-04885a25df4f
                © 2019 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals, Inc.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 28 September 2019
                : 05 October 2019
                Page count
                Figures: 8, Tables: 1, Pages: 9, Words: 4758
                Funding
                Funded by: Biotronik , open-funder-registry 10.13039/501100005035;
                Award ID: Scaffolds for testing were provided
                Categories
                Coronary Artery Disease
                Coronary Artery Disease
                Basic Science
                Custom metadata
                2.0
                December 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.6 mode:remove_FC converted:22.12.2020

                bifurcations,bioresorbable scaffolds,mechanical properties,percutaneous coronary intervention,stent,stenting technique,strut fracture

                Comments

                Comment on this article